Upload
evan-gross
View
35
Download
1
Embed Size (px)
Citation preview
MalesN=887
73%
FemalesN=334
27%
Total 1221100%
New Jersey Basic Life Support Emergency Medical Services Naloxone Analysis
Evan Gross, Intern Dr. Terry Clancy, Preceptor
New Jersey Department of Health, OEMS
72%
20%
8%
Statewide Patient Responses to Naloxone Administration
• Patient response 72%, n=878; (i.e., alert, oriented, confused, vomiting, combative)
• No patient response (20%, n=241)
• Unknown or other (8%, n=102)
• To analyze the Naloxone (Narcan®) Basic Life Support (BLS) program data for New Jersey and make policy recommendations to improve pre-hospital response to opioid overdoses.
Photo obtained from http://bit.ly/1eSxqf8
• Opioid abuse has increased nationally and in New Jersey over the past two decades.
• Overdose Prevention Act authorized Emergency Medical Technicians (EMTs) to administer Naloxone.
• Naloxone administration data in New Jersey has been collected, not analyzed thus far.
Purpose
• A special thank you to Dr. Terry Clancy, Internship Preceptor, Ann Marie Hill, Internship Coordinator, and the Office of Emergency Medical Services staff for their guidance.
• Variables identified can be further analyzed to identify gaps in Naloxone administration, MAR reporting, and treatment strategies.
• Analysis provides OEMS with target populations to enhance treatment and prevention initiatives to improve the public health response to the opioid epidemic.
Evaluation
Acknowledgements
Significance
Method/Approach
1,221 MARs remainedAnalyzed to evaluate trends in Naloxone
administration
152 MARs removed - do not fit criteria(i.e., practice MARs, unregistered police & fire
agencies, & administrations that deviated from protocol)
Retrospective review of 1,373 NJ BLS Naloxone Medication Administration Reports (MARs)
(April 2014-December 2015)
#1 Camden #2 Ocean #3 Hudson0
50
100
150
200
250
300
350
400
450
398
129 128
NJ counties with greatest # of administrations
Apr 2014 – Dec 2015
County
# of
Adm
inis
trati
ons
Statewide age groups with greatest # of Naloxone administrations
#1: 20-29 years of age 453 (37.1% of administrations)
#2: 30-39 years of age330 (27.0% of administrations)
#3: 40-49 years of age205 (16.8% of administrations)
Outcomes